Hypoglycemia as a Result of Propranolol During Treatment of Infantile Hemangioma: A Case Report

被引：52

作者：

Breur, Johannes M. P. J. ^{[1
]}

de Graaf, Marlies ^{[2
]}

Breugem, Corstiaan C. ^{[3
]}

Pasmans, Suzanne G. M. A. ^{[2
]}

机构：

[1] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Ctr Congenital Vasc Anomalies Utrecht, Dept Pediat Cardiol, NL-3584 EA Utrecht, Netherlands

[2] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Ctr Congenital Vasc Anomalies Utrecht, Dept Pediat Dermatol & Allergol, NL-3584 EA Utrecht, Netherlands

[3] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Ctr Congenital Vasc Anomalies Utrecht, Dept Pediat Plast Surg, NL-3584 EA Utrecht, Netherlands

来源：

PEDIATRIC DERMATOLOGY | 2011年 / 28卷 / 02期

关键词：

D O I：

10.1111/j.1525-1470.2010.01224.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Propranolol is a new and promising treatment for hemangiomas of infancy. We report of a patient in whom steroid maintenance therapy is successfully tapered after introduction of propranolol. This patient, however, developed symptomatic hypoglycemic events presumably because of a concurrent deficiency of epinephrine and cortisol as a direct result of both beta-blockage by propranolol and adrenal insufficiency as a result of prednisone use. Extreme care should be taken in patients treated with both propranolol and prednisone as they are at increased risk of hypoglycemia.

引用

页码：169 / 171

页数：3

共 10 条

[1] Hypoglycemia and propranolol in pediatric behavioral disorders [J].